Labetalol hydrochloride and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Labetalol hydrochloride (labetalol hydrochloride), especially for people who are female, 60+ old, also take Lomotil, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Labetalol hydrochloride. It is created by eHealthMe based on reports of 1,981 people who have side effects when taking Labetalol hydrochloride from the FDA, and is updated regularly.

What is Labetalol hydrochloride?

Labetalol hydrochloride has active ingredients of labetalol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,413 Labetalol hydrochloride users. Check the latest studies of Labetalol hydrochloride.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,887 drugs and 2,613 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

On Jul, 07, 2026

1,981 people reported to have side effects when taking Labetalol hydrochloride.
Among them, 18 people (0.91%) have Intestinal obstruction.

Could Labetalol hydrochloride cause Intestinal obstruction?

Among these 18 people:

What is the gender of people who have Intestinal obstruction when taking Labetalol hydrochloride? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Intestinal obstruction when taking Labetalol hydrochloride? *

What are other drugs people take besides Labetalol hydrochloride? *

What are other side effects people have besides Intestinal obstruction? *

Fall: 14 people, 77.78%
Diarrhea: 14 people, 77.78%
Weight Decreased: 12 people, 66.67%
Weight Increased: 11 people, 61.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 61.11%
Gingival Infection (gum infection): 11 people, 61.11%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 11 people, 61.11%
Head Injury: 11 people, 61.11%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 11 people, 61.11%
Histoplasmosis (infection caused by breathing in spores of a fungus): 11 people, 61.11%

What are the existing conditions these people have? *

Stress And Anxiety: 11 people, 61.11%
Pain In Jaw: 11 people, 61.11%
Multiple Myeloma (cancer of the plasma cells): 11 people, 61.11%
Immunodeficiency Common Variable: 3 people, 16.67%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Labetalol hydrochloride and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Labetalol hydrochloride:

Labetalol hydrochloride (2,413 reports)

Browse all side effects of Labetalol hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,887 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on labetalol hydrochloride (the active ingredients of Labetalol hydrochloride) and Labetalol hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.